H. Pavenstadt, W. Kriz, and M. Kretzler, Cell biology of the glomerular podocyte, Physiol Rev, vol.83, p.12506131, 2003.

A. J. Collins, R. N. Foley, C. Herzog, B. Chavers, D. Gilbertson et al., US Renal Data System 2010 Annual Data Report, Am J Kidney Dis, vol.57, p.21184928, 2011.

C. Schell and T. B. Huber, New players in the pathogenesis of focal segmental glomerulosclerosis, Nephrol Dial Transplant, vol.27, p.22767631, 2012.

M. Zenker, E. Machuca, and C. Antignac, Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier, J Mol Med (Berl), vol.87, pp.849-857, 2009.

M. Vinai, P. Waber, and M. G. Seikaly, Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review, Pediatr Transplant, vol.14, p.20519016, 2010.

G. Canaud, D. Dion, J. Zuber, M. C. Gubler, R. Sberro et al., Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS), Nephrol Dial Transplant, vol.25, p.19773419, 2010.

G. Canaud, J. Zuber, R. Sberro, V. Royale, D. Anglicheau et al., Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study, Am J Transplant, vol.9, p.19344432, 2009.

S. M. Feld, P. Figueroa, V. Savin, C. C. Nast, R. Sharma et al., Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys, Am J Kidney Dis, vol.32, p.9708606, 1998.

M. Haas, Y. Godfrin, R. Oberbauer, N. Yilmaz, K. Borchhardt et al., Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis, Nephrol Dial Transplant, vol.13, p.9719156, 1998.

J. Dantal, E. Bigot, W. Bogers, A. Testa, F. Kriaa et al., Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome, N Engl J Med, vol.330, p.8259160, 1994.

S. W. Zimmerman, Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation, Clin Nephrol, vol.22, p.6383672, 1984.

R. Coppo, Different targets for treating focal segmental glomerular sclerosis, Contrib Nephrol, vol.181, p.23689570, 2013.

E. T. Mccarthy, M. Sharma, and V. J. Savin, Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis, Clin J Am Soc Nephrol, vol.5, p.20966123, 2010.

V. J. Savin, E. T. Mccarthy, and M. Sharma, Permeability factors in focal segmental glomerulosclerosis, Semin Nephrol, vol.23, p.12704575, 2003.

M. Delville, T. K. Sigdel, C. Wei, J. Li, S. C. Hsieh et al., A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation, Sci Transl Med, vol.6, pp.256-136, 2014.

L. Laconte and K. Mukherjee, Structural constraints and functional divergences in CASK evolution, Biochem Soc Trans, vol.41, p.23863172, 2013.

S. Lehtonen, E. Lehtonen, K. Kudlicka, H. Holthofer, and M. G. Farquhar, Nephrin forms a complex with adherens junction proteins and CASK in podocytes and in Madin-Darby canine kidney cells expressing nephrin, Am J Pathol, vol.165, p.15331416, 2004.

G. Caruana, Genetic studies define MAGUK proteins as regulators of epithelial cell polarity, Int J Dev Biol, vol.46, p.12141438, 2002.

M. Uhlen, E. Bjorling, C. Agaton, C. A. Szigyarto, B. Amini et al., A human protein atlas for normal and cancer tissues based on antibody proteomics, Mol Cell Proteomics, vol.4, p.16127175, 2005.

Y. Yan, G. Dalmasso, S. Sitaraman, and D. Merlin, Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma, Am J Physiol Gastrointest Liver Physiol, vol.292, p.17023546, 2007.

Y. Yan, S. Vasudevan, H. Nguyen, U. Bork, S. Sitaraman et al., Extracellular interaction between hCD98 and the PDZ class II domain of hCASK in intestinal epithelia, J Membr Biol, vol.215, p.17437146, 2007.

S. Cai, N. Bulus, P. M. Fonseca-siesser, D. Chen, S. K. Hanks et al., CD98 modulates integrin beta1 function in polarized epithelial cells, J Cell Sci, vol.118, p.15713750, 2005.

S. Beaudreuil, X. Zhang, F. Kriaa, J. Dantal, H. Francois et al., Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis, Nephrol Dial Transplant, vol.29, p.24235085, 2014.

A. Shevchenko, I. Chernushevich, M. Wilm, and M. Mann, De Novo peptide sequencing by nanoelectrospray tandem mass spectrometry using triple quadrupole and quadrupole/time-of-flight instruments, Methods Mol Biol, vol.146, p.10948493, 2000.

P. Mundel, H. W. Heid, T. M. Mundel, M. Kruger, J. Reiser et al., Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes, J Cell Biol, vol.139, p.9314539, 1997.

C. Wei, E. Hindi, S. Li, J. Fornoni, A. Goes et al., Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis, Nat Med, vol.17, p.21804539, 2011.

D. Schlondorff, Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?, Kidney Int, vol.85, p.24583981, 2014.

N. Sidenius, C. F. Sier, H. Ullum, B. K. Pedersen, A. C. Lepri et al., Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection, Blood, vol.96, p.11110678, 2000.

C. F. Sier, R. Stephens, J. Bizik, A. Mariani, M. Bassan et al., The level of urokinasetype plasminogen activator receptor is increased in serum of ovarian cancer patients, Cancer Res, vol.58, p.9581823, 1998.

S. Hayashi, D. T. Uehara, K. Tanimoto, S. Mizuno, Y. Chinen et al., Comprehensive investigation of CASK mutations and other genetic etiologies in 41 patients with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH), PLoS One, vol.12, p.28783747, 2017.

L. Mastroberardino, B. Spindler, R. Pfeiffer, P. J. Skelly, J. Loffing et al., Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family, Nature, vol.395, p.9751058, 1998.

F. Verrey, E. I. Closs, C. A. Wagner, M. Palacin, H. Endou et al., CATs and HATs: the SLC7 family of amino acid transporters, Pflugers Arch, vol.447, p.14770310, 2004.

F. Verrey, C. Meier, G. Rossier, and L. C. Kuhn, Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity, Pflugers Arch, vol.440, p.10958334, 2000.

E. Boulter, S. Estrach, A. Errante, C. Pons, L. Cailleteau et al., CD98hc (SLC3A2) regulation of skin homeostasis wanes with age, J Exp Med, vol.210, p.23296466, 2013.

C. A. Fenczik, T. Sethi, J. W. Ramos, P. E. Hughes, and M. H. Ginsberg, Complementation of dominant suppression implicates CD98 in integrin activation, Nature, vol.390, p.9363894, 1997.

C. C. Feral, N. Nishiya, C. A. Fenczik, H. Stuhlmann, M. Slepak et al., CD98hc (SLC3A2) mediates integrin signaling, Proc Natl Acad Sci U S A, vol.102, p.15625115, 2005.

C. C. Feral, A. Zijlstra, E. Tkachenko, G. Prager, M. L. Gardel et al., CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling, J Cell Biol, vol.178, p.17682053, 2007.

K. Asanuma and P. Mundel, The role of podocytes in glomerular pathobiology, Clin Exp Nephrol, vol.7, p.14712353, 2003.

D. Vd, The spectrum of focal segmental glomerulosclerosis: new insights, Curr Opin Nephrol Hypertens, vol.17, p.18408478, 2008.

A. B. Fogo, Animal models of FSGS: lessons for pathogenesis and treatment, Semin Nephrol, vol.23, p.12704576, 2003.

M. Gigante, P. Pontrelli, E. Montemurno, L. Roca, F. Aucella et al., CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS), Nephrol Dial Transplant, vol.24, p.19131354, 2009.

P. Kaltenis, V. Schumacher, A. Jankauskiene, A. Laurinavicius, and B. Royer-pokora, Slow progressive FSGS associated with an F392L WT1 mutation, Pediatr Nephrol, vol.19, p.14745636, 2004.

Y. Maezawa, T. Onay, R. P. Scott, L. S. Keir, H. Dimke et al., Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS, J Am Soc Nephrol, vol.25, p.24904088, 2014.

J. L. Michaud, K. M. Chaisson, R. J. Parks, and C. R. Kennedy, FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes, Kidney Int, vol.70, p.16837921, 2006.

J. Y. Cho, K. M. Skubitz, D. R. Katz, and B. M. Chain, CD98-dependent homotypic aggregation is associated with translocation of protein kinase Cdelta and activation of mitogen-activated protein kinases, Exp Cell Res, vol.286, p.12729789, 2003.